Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Supaporn Phumiamorn"'
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisutthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 wit
Externí odkaz:
https://doaj.org/article/0629312cc945435bb6f6a4a61ad5c035
Autor:
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-11 (2022)
Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) have been shown to be insufficient to protect against variants of concern (VOCs), while vir
Externí odkaz:
https://doaj.org/article/6b2a8a0b69ec469290d4a9c679d25e11
Autor:
Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom, Sompong Sapsutthipas, Rujipas Sirijatuphat, Orasri Wittawatmongkol, Sansnee Senawong, Surakameth Mahasirimongkol, Sakalin Trisiriwanich, Kulkanya Chokephaibulkit
Publikováno v:
Vaccine: X, Vol 10, Iss , Pp 100153- (2022)
Background: Inactivated vaccine (CoronaVac) and chimpanzee adenovirus-vector vaccine (ChAdOx1) have been widely used in resource-limited settings. However, the information on the reactogenicity and immunogenicity of these two vaccines in the same set
Externí odkaz:
https://doaj.org/article/3c35a05b20af4615be50ab5732a280fa
Autor:
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, Sansnee Senawong, Chatkamol Pheerapanyawaranun, Supaporn Phumiamorn, Paul V. Licciardi, Kulkanya Chokephaibulkit
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1497 (2022)
Intradermal vaccination using fractional dosages of the standard vaccine dose is one strategy to improve access to COVID-19 immunization. We conducted a pilot study in healthy adults in Thailand to evaluate the safety and immunogenicity of intraderma
Externí odkaz:
https://doaj.org/article/46aa3c94e5274601832b56273107a4d2
Autor:
Nawamin Pinpathomrat, Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Ratchanon Sophonmanee, Jariya Hengprakop, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Chanon Kongkamol, Thammasin Ingviya, Pasuree Sangsupawanich, Sarunyou Chusri
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/be314c318a9949b3be85d8fbe0127e37
Autor:
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj, Kaewta Rattanapisit, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Eakachai Prompetchara, Chutitorn Ketloy, Supranee Buranapraditkun, Wassana Wijagkanalan, Kittipan Tharakhet, Papatsara Kaewpang, Kantinan Leetanasaksakul, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Kiat Ruxrungtham, Arunee Thitithanyanont, Waranyoo Phoolcharoen
Publikováno v:
Frontiers in Plant Science, Vol 12 (2021)
The emergence of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected global public health and economy. Despite the substantial efforts, only few vaccines are currently approved and s
Externí odkaz:
https://doaj.org/article/81a79f5c339541419da793cc68622f90
Autor:
Eakachai Prompetchara, Chutitorn Ketloy, Kittipan Tharakhet, Papatsara Kaewpang, Supranee Buranapraditkun, Teerasit Techawiwattanaboon, Suwitra Sathean-Anan-Kun, Patrawadee Pitakpolrat, Supaporn Watcharaplueksadee, Supaporn Phumiamorn, Wassana Wijagkanalan, Kanitha Patarakul, Tanapat Palaga, Kiat Ruxrungtham
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248007 (2021)
More than 65 million people have been confirmed infection with SARS-CoV-2 and more than 1 million have died from COVID-19 and this pandemic remains critical worldwide. Effective vaccines are one of the most important strategies to limit the pandemic.
Externí odkaz:
https://doaj.org/article/bb033a1145814d198244321dd244e718
Autor:
Surakameth Mahasirimongkol, Athiwat Khunphon, Oraya Kwangsukstid, Sompong Sapsutthipas, Mingkwan Wichaidit, Archawin Rojanawiwat, Nuanjun Wichuckchinda, Wiroj Puangtubtim, Warangluk Pimpapai, Sakulrat Soonthorncharttrawat, Asawin Wanitchang, Anan Jongkaewwattana, Kanjana Srisutthisamphan, Daraka Phainupong, Naphatcha Thawong, Pundharika Piboonsiri, Waritta Sawaengdee, Thitiporn Somsaard, Kanokphon Ritthitham, Supaporn Chumpol, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Panadda Dhepakson, Sopon Iamsirithaworn, Supaporn Phumiamorn
Publikováno v:
Vaccines, Vol 10, Iss 4, p 536 (2022)
In response to the SARS-CoV-2 Delta variant, which partially escaped the vaccine-induced immunity provided by two doses of vaccination with CoronaVac (Sinovac), the National Vaccine Committee recommended the heterologous CoronaVac-ChAdOx1 (Oxford–A
Externí odkaz:
https://doaj.org/article/518ddbc5fd4a4ebe97eaf658e10ba8ca
Autor:
Porntip Intapiboon, Purilap Seepathomnarong, Jomkwan Ongarj, Smonrapat Surasombatpattana, Supattra Uppanisakorn, Surakameth Mahasirimongkol, Waritta Sawaengdee, Supaporn Phumiamorn, Sompong Sapsutthipas, Pasuree Sangsupawanich, Sarunyou Chusri, Nawamin Pinpathomrat
Publikováno v:
Vaccines, Vol 9, Iss 12, p 1375 (2021)
Effective vaccine coverage is urgently needed to tackle the COVID-19 pandemic. Inactivated vaccines have been introduced in many countries for emergency usage, but have only provided limited protection. Heterologous vaccination is a promising strateg
Externí odkaz:
https://doaj.org/article/da9cc1c7267c4917ac69883e113a4f13
Autor:
Tuksin Jearanaiwitayakul, Mathurin Seesen, Runglawan Chawengkirttikul, Jitra Limthongkul, Suttikarn Apichirapokey, Sompong Sapsutthipas, Supaporn Phumiamorn, Panya Sunintaboon, Sukathida Ubol
Publikováno v:
Vaccines, Vol 9, Iss 7, p 768 (2021)
Mucosal immunity plays a significant role in host defense against viruses in the respiratory tract. Because the upper respiratory airway is a primary site of SARS-CoV-2 entry, immunization at the mucosa via the intranasal route could potentially lead
Externí odkaz:
https://doaj.org/article/e362ce9749644d1e8a1cf3166860c5a1